NL-OMON46964
Completed
Not Applicable
A prospective clinical follow up study with a New Press-fit Cup with initial RSA analysis (NPC). - ANEXYS TRIA
Stichting SCORE0 sites28 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Osteoarthritis
- Sponsor
- Stichting SCORE
- Enrollment
- 28
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial ended prematurely
Investigators
Eligibility Criteria
Inclusion Criteria
- •Suffer from primary or secondary coxarthrosis. \* Be ready to participate in the follow\-up examinations mentioned above \* Be between 18 and 85 years old at the time of inclusion \* Be a candidate for a primary implantation of a hip endoprosthesis \* Be expected to recover completely \* Have a BMI of 35 or less
Exclusion Criteria
- •\* Simultaneous participation in another clinical study or documentation with other orthopaedic implants of competitors. \* Suffer from the exclusion criteria: sepsis or malignant tumours. \* Have an ASA Classification \> 3\. \* Have a revision surgery
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A prospective, multicenter clinical study to evaluate the safety profile of the FlexiSurge Adhesion Barrier for the prevention of intra-abdominal adhesion formation after laparotomyvorming van adhesies na buikchirurgieadhesion formationpostoperative adhesionsNL-OMON40303Medisse BV5
Completed
Not Applicable
A randomized prospective clinical trial comparing OsteoActivator-P coated membranes vs Collagen Membrane-P uncoated for accelerated localized alveolar ridge preservation.dentaalloss of bone volumeNL-OMON51997Osteo-Pharma.B.V.16
Completed
Phase 3
A Phase 3, Randomized, Open-label Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined with Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence (PIVOT-12)MelanomaSkin cancer1004090010035023NL-OMON55317ektar Therapeutics12
Completed
Phase 3
A Phase 3 Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of Dexamethasone Plus MLN9708 or Physician's Choice of Treatment Administered to Patients With Relapsed or Refractory Systemic Light Chain (AL) Amyloidosisprimary amyloidosisprimary systemic amyloidosis (PSA)10035227NL-OMON50586Millenium Pharmaceuticals7
Completed
Phase 2
A nationwide open-label multi-center prospective cohort study of nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer'pancreatic adenocarcinoma' 'pancreatic cancer'10017991NL-OMON46852Academisch Medisch Centrum15